FDA Inspection 892573 — Ipsen BioPharm Ltd
The FDA completed an inspection of Ipsen BioPharm Ltd on July 8, 2014 in Wrexham. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 8, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wrexham (United Kingdom)
Citations
| ID | CFR | Description |
|---|---|---|
| 4576 | 21 CFR 211.192 | No written record of investigation |